Eight (26.6 %) levosimendan patients and 13 (43.3 %) placebo patients experienced renal incidents (as defined by the authors), though this difference did not reach statistical significance ( p = 0.167).
1
0.1670
0.1670
Eight (26.6 %) levosimendan patients and 13 (43.3 %) placebo patients experienced renal incidents (as defined by the authors), though this difference did not reach statistical significance ( p = 0.167).